- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on No-Reflow Phenomenon in Hong Kong
Total 35 results
-
Chinese University of Hong KongRecruitingGastro Esophageal RefluxHong Kong
-
Chinese University of Hong KongUnknownGastro-esophageal Reflux DiseaseHong Kong
-
Chinese University of Hong KongRecruitingObesity | Gastro Esophageal Reflux DiseaseChina
-
Chinese University of Hong KongUnknownGastroesophageal Reflux DiseaseHong Kong
-
MuhammadNot yet recruitingGastroesophageal Reflux DiseaseHong Kong
-
Chinese University of Hong KongRecruiting
-
Chinese University of Hong KongCompletedFunctional Dyspepsia | Irritable Bowel Syndrome | Non-erosive Gastroesophageal Reflux DiseaseHong Kong
-
Chinese University of Hong KongRecruiting
-
Hospital Authority, Hong KongThe University of Hong KongUnknown
-
Chinese University of Hong KongCompletedGastroesophageal Reflux DiseaseChina
-
Chinese University of Hong KongCompleted
-
Chinese University of Hong KongCompletedGastroesophageal Reflux DiseaseChina
-
Hospital Authority, Hong KongThe University of Hong KongUnknown
-
Chinese University of Hong KongRecruitingGastroesophageal RefluxHong Kong
-
Hospital Authority, Hong KongThe University of Hong KongCompletedGastroesophageal Reflux | LaryngitisChina
-
Chinese University of Hong KongTerminated
-
Chinese University of Hong KongCompletedNormal Blood Pressure | Biopsy-confirmed IgA Nephropathy | Proteinuria Less Than 0.5 g Per Day | Serum Creatinine Below 120 Umol/lHong Kong
-
Chinese University of Hong KongCompletedDyspepsia | Gastroesophageal Reflux | Peptic Ulcer Disease | Pancreatobiliary Disease | Ugi MalignanciesHong Kong
-
TakedaCompletedGastroesophageal Reflux DiseaseHong Kong, Korea, Republic of, Taiwan
-
Naveed NatanziUnknownno ConditionsUnited States
-
AstraZenecaCompletedGastroesophageal Reflux DiseaseVietnam
-
Eagle Pharmaceuticals, Inc.CompletedCancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is AppropriateUnited States
-
Janssen Research & Development, LLCEisai Inc.CompletedGastroesophageal Reflux Disease (GERD)United States, Poland, United Kingdom, Belgium, Brazil
-
VA Office of Research and DevelopmentCompleted
-
Braintree LaboratoriesActive, not recruitingNon-erosive Reflux DiseaseUnited States
-
AstraZenecaCompletedGastroesophageal RefluxBulgaria, Italy, South Africa, Spain, Hungary, Canada, Hong Kong, Greece, Germany, Australia, United Kingdom
-
TakedaCompletedGastroesophageal Reflux Disease | HeartburnChina
-
TakedaCompletedGastroesophageal Reflux Disease (GERD)United Kingdom, Australia, Belgium, Spain, Austria, Germany, Argentina, Brazil, Canada, France, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Mexico, Poland, Portugal, Singapore, South Africa, Switzerland, Taiwan
-
TakedaCompletedGastroesophageal Reflux DiseaseUnited States
-
TakedaCompletedGastroesophageal Reflux DiseaseUnited States
-
TakedaCompletedEsophagitis, Peptic | Esophagitis, RefluxUnited States
-
TakedaCompletedGastroesophageal RefluxUnited States
-
TakedaCompletedEsophagitis, Peptic | Esophagitis, RefluxUnited States, Poland, Bulgaria, India, South Africa, Canada, Peru, New Zealand, Australia, Lithuania, Slovakia, Hungary, Latvia, Germany, Czech Republic
-
AstraZenecaCompleted
-
Abbott Medical DevicesActive, not recruiting